MAHLY Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (10 Jun 2024 @ 19:08):
Our systems believe the stock currently is undervalued by 3.61% compare to its pairs and should correct upwards.

Stats
Tagesvolumen	107
Durchschnittsvolumen	33
Marktkapitalisierung	3.09B
EPS	$62.80 ( Q4 \| 2024-03-31 )
Nächstes Ertragsdatum	( $0 ) 2024-07-31
Last Dividend	$0.185 ( 2021-09-28 )
Next Dividend	$0 ( N/A )
P/E	11.75 (Sector) 0 (Industry) 0
ATR14	$0 (0.00%)

CAKFY 0.00%

MAHLY 0.00%

Korrelation (AI algo v.1.1b): Undervalued: 3.61% $15.77 paired level. (Der Algorithmus verfolgt in Echtzeit die Änderungen der am stärksten korrelierten Aktien und gibt eine sofortige Aktualisierung)

MediPal Holdings Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

MediPal Holdings Finanzdaten

Annual	2024
Umsatz:	$3 558.73B
Bruttogewinn:	$233.01B (6.55 %)
EPS:	$195.84

FY	2024
Umsatz:	$3 558.73B
Bruttogewinn:	$233.01B (6.55 %)
EPS:	$195.84

FY	2023
Umsatz:	$3 360.01B
Bruttogewinn:	$212.12B (6.31 %)
EPS:	$184.82

FY	2022
Umsatz:	$3 290.92B
Bruttogewinn:	$205.11B (6.23 %)
EPS:	$140.13

Financial Reports:

No articles found.

MediPal Holdings Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

MediPal Holdings Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.45 - low (47.74%) | Divividend Growth Potential Score: 1.119 - No dividend expected

Information

First Dividend	$0.191	2021-03-29
Last Dividend	$0.185	2021-09-28
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	$0.376	--
Avg. Dividend % Per Year	0.00%	--
Score	1.85	--
Div. Sustainability Score	4.45
Div.Growth Potential Score	1.119
Div. Directional Score	2.78	--

Next Divdend (Est)
(2024-12-19)

$0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

1.85

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
28 Sep 2021	$0.185	30 Nov -0001	30 Nov -0001	30 Nov -0001
29 Mar 2021	$0.191	30 Nov -0001	30 Nov -0001	30 Nov -0001

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
NSARO	Ex Dividend Junior	2023-07-07	Quarterly	0.00%
BDVSY	Ex Dividend Junior	2023-09-28	Annually	0.00%
JAIRF	Ex Dividend Junior	2023-09-28	Annually	0.00%
UNTC	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%
FBTT	Ex Dividend Knight	2023-09-21	Quarterly	0.00%
REMYY	Ex Dividend Junior	2023-09-26	Annually	0.00%
CKNQP	Ex Dividend Junior	2023-09-14	Quarterly	0.00%
LZRFY	Ex Dividend Junior	2023-07-03	Bi-Monthly	0.00%
AILLO	Ex Dividend Knight	2023-07-14	Semi-Annually	0.00%
HEINY	Ex Dividend Knight	2023-08-10	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0117	1.500	9.77	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0231	1.200	9.23	10.00	[0 - 0.3]
returnOnEquityTTM	0.0708	1.500	-0.325	-0.487	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.235	0.800	8.83	7.06	[1 - 3]
quickRatioTTM	1.047	0.800	8.55	6.84	[0.8 - 2.5]
cashRatioTTM	0.228	1.500	9.84	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	6 442.12	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.0655	1.000	-2.24	-2.24	[0.2 - 0.8]
operatingProfitMarginTTM	0.0145	1.000	-1.710	-1.710	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	1.978	0.800	0.146	0.117	[0.5 - 2]
Total Score				4.45

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	11.98	1.000	8.89	0	[1 - 100]
returnOnEquityTTM	0.0708	2.50	-0.209	-0.487	[0.1 - 1.5]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
dividendYielPercentageTTM	0.0151	1.500	9.62	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0323	1.500	-3.12	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				1.119

MediPal Holdings Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.